• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Axon degeneration: mechanistic insights lead to therapeutic opportunities for the prevention and treatment of peripheral neuropathy.轴突变性:机制研究为预防和治疗周围神经病提供了治疗机会。
Pain. 2019 May;160 Suppl 1(Suppl 1):S17-S22. doi: 10.1097/j.pain.0000000000001528.
2
SARM1-Dependent Axon Degeneration: Nucleotide Signaling, Neurodegenerative Disorders, Toxicity, and Therapeutic Opportunities.SARM1 依赖性轴突变性:核苷酸信号、神经退行性疾病、毒性和治疗机会。
Neuroscientist. 2024 Aug;30(4):473-492. doi: 10.1177/10738584231162508. Epub 2023 Mar 31.
3
Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy.药物性 SARM1 抑制可保护紫杉醇诱导的周围神经病变中的轴突结构和功能。
Brain. 2021 Nov 29;144(10):3226-3238. doi: 10.1093/brain/awab184.
4
Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program.长春新碱和硼替佐米通过不同的上游机制激活一个共同的 SARM1 依赖性轴突退化程序。
JCI Insight. 2019 Sep 5;4(17):129920. doi: 10.1172/jci.insight.129920.
5
Axons Matter: The Promise of Treating Neurodegenerative Disorders by Targeting SARM1-Mediated Axonal Degeneration.轴突至关重要:通过靶向 SARM1 介导的轴突变性治疗神经退行性疾病的前景。
Trends Pharmacol Sci. 2020 Apr;41(4):281-293. doi: 10.1016/j.tips.2020.01.006. Epub 2020 Feb 24.
6
Augustus Waller's foresight realized: SARM1 in peripheral neuropathies.奥古斯都·沃勒有先见之明:SARM1 在周围神经病变中的作用。
Curr Opin Neurobiol. 2024 Aug;87:102884. doi: 10.1016/j.conb.2024.102884. Epub 2024 Jun 8.
7
cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons.钙依赖激活调节蛋白(cADPR)是 SARM1 活性在健康、受损和退化轴突中的基因剂量敏感生物标志物。
Exp Neurol. 2020 Jul;329:113252. doi: 10.1016/j.expneurol.2020.113252. Epub 2020 Feb 19.
8
Nicotinic acid mononucleotide is an allosteric SARM1 inhibitor promoting axonal protection.烟酰胺单核苷酸是一种别构 SARM1 抑制剂,可促进轴突保护。
Exp Neurol. 2021 Nov;345:113842. doi: 10.1016/j.expneurol.2021.113842. Epub 2021 Aug 14.
9
Gene therapy targeting SARM1 blocks pathological axon degeneration in mice.基因治疗靶向 SARM1 可阻止小鼠病理性轴突变性。
J Exp Med. 2019 Feb 4;216(2):294-303. doi: 10.1084/jem.20181040. Epub 2019 Jan 14.
10
DLK Activation Synergizes with Mitochondrial Dysfunction to Downregulate Axon Survival Factors and Promote SARM1-Dependent Axon Degeneration.DLK 激活与线粒体功能障碍协同作用,下调轴突存活因子并促进 SARM1 依赖性轴突退化。
Mol Neurobiol. 2020 Feb;57(2):1146-1158. doi: 10.1007/s12035-019-01796-2. Epub 2019 Nov 7.

引用本文的文献

1
Curcumin as a promising therapeutic agent for diabetic neuropathy: from molecular mechanisms to functional recovery.姜黄素作为治疗糖尿病神经病变的一种有前景的治疗药物:从分子机制到功能恢复
Diabetol Metab Syndr. 2025 Aug 5;17(1):314. doi: 10.1186/s13098-025-01884-5.
2
Mitochondrial dynamics in diabetic peripheral neuropathy: Pathogenesis, progression, and therapeutic approaches.糖尿病周围神经病变中的线粒体动力学:发病机制、进展及治疗方法
Medicine (Baltimore). 2025 Jul 18;104(29):e42748. doi: 10.1097/MD.0000000000042748.
3
Transcranial magnetic stimulation measures of corticospinal excitability in Black and Hispanic/Latino people with painful peripheral neuropathy.黑人及西班牙裔/拉丁裔疼痛性周围神经病变患者皮质脊髓兴奋性的经颅磁刺激测量
Front Hum Neurosci. 2025 Jun 2;19:1551931. doi: 10.3389/fnhum.2025.1551931. eCollection 2025.
4
The role of L-DOPA in neurological and neurodegenerative complications: a review.左旋多巴在神经和神经退行性并发症中的作用:综述
Mol Cell Biochem. 2025 Jun 9. doi: 10.1007/s11010-025-05324-w.
5
Inhibition of SARM1 Reduces Neuropathic Pain in a Spared Nerve Injury Rodent Model.抑制含 sterile α 和 armadillo 基序的蛋白 1(SARM1)可减轻 spared 神经损伤啮齿动物模型中的神经性疼痛。
Muscle Nerve. 2025 Apr;71(4):670-679. doi: 10.1002/mus.28367. Epub 2025 Feb 12.
6
Feasibility of trancutaneous auricular vagus nerve stimulation in Black and Hispanic/Latino people with peripheral neuropathy.经皮耳迷走神经刺激在患有周围神经病变的黑人和西班牙裔/拉丁裔人群中的可行性。
Front Pain Res (Lausanne). 2025 Jan 17;5:1516196. doi: 10.3389/fpain.2024.1516196. eCollection 2024.
7
Transdermal electrophysiological recordings of diet-induced small fiber peripheral neuropathy using a needle electrode array in mice and man.使用针电极阵列对小鼠和人类饮食诱导的小纤维周围神经病变进行经皮电生理记录。
Front Bioeng Biotechnol. 2025 Jan 10;12:1511383. doi: 10.3389/fbioe.2024.1511383. eCollection 2024.
8
Gap junction intercellular communications regulates activation of SARM1 and protects against axonal degeneration.缝隙连接细胞间通讯调节SARM1的激活并预防轴突变性。
Cell Death Dis. 2025 Jan 14;16(1):13. doi: 10.1038/s41419-025-07342-4.
9
A call to action for peripheral neuropathy research funding-Time to consolidate funding under one NIH initiative?呼吁为周围神经病变研究提供资金——是时候通过一项美国国立卫生研究院倡议来整合资金了吗?
J Peripher Nerv Syst. 2025 Mar;30(1):e12681. doi: 10.1111/jns.12681.
10
Exploring clinical markers of Axon degeneration processes in Chemotherapy-induced peripheral neuropathy among young adults receiving vincristine or paclitaxel.探讨接受长春新碱或紫杉醇治疗的年轻成年人化疗诱导性周围神经病中轴索退变过程的临床标志物。
BMC Neurol. 2024 Sep 28;24(1):366. doi: 10.1186/s12883-024-03877-9.

本文引用的文献

1
Gene therapy targeting SARM1 blocks pathological axon degeneration in mice.基因治疗靶向 SARM1 可阻止小鼠病理性轴突变性。
J Exp Med. 2019 Feb 4;216(2):294-303. doi: 10.1084/jem.20181040. Epub 2019 Jan 14.
2
Death, TIR, and RHIM: Self-assembling domains involved in innate immunity and cell-death signaling.死亡结构域(TIR)、RHIM 结构域:参与天然免疫和细胞死亡信号转导的自我组装结构域。
J Leukoc Biol. 2019 Feb;105(2):363-375. doi: 10.1002/JLB.MR0318-123R. Epub 2018 Dec 5.
3
Therapeutic opportunities and pitfalls in the treatment of axon degeneration.治疗轴突变性的治疗机会和陷阱。
Curr Opin Neurol. 2018 Dec;31(6):693-701. doi: 10.1097/WCO.0000000000000621.
4
Pharmacological bypass of NAD salvage pathway protects neurons from chemotherapy-induced degeneration.药理学旁路 NAD 补救途径可保护神经元免受化疗诱导的退化。
Proc Natl Acad Sci U S A. 2018 Oct 16;115(42):10654-10659. doi: 10.1073/pnas.1809392115. Epub 2018 Sep 26.
5
An updated understanding of the mechanisms involved in chemotherapy-induced neuropathy.对化疗诱导的神经病变所涉及机制的最新认识。
Pain Manag. 2018 Sep 1;8(5):363-375. doi: 10.2217/pmt-2018-0020. Epub 2018 Sep 13.
6
Palmitoylation enables MAPK-dependent proteostasis of axon survival factors.棕榈酰化使轴突存活因子的 MAPK 依赖性蛋白稳定。
Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):E8746-E8754. doi: 10.1073/pnas.1806933115. Epub 2018 Aug 27.
7
An axonal stress response pathway: degenerative and regenerative signaling by DLK.一种轴突应激反应通路:DLK 的退行性和再生信号。
Curr Opin Neurobiol. 2018 Dec;53:110-119. doi: 10.1016/j.conb.2018.07.002. Epub 2018 Jul 24.
8
PAM forms an atypical SCF ubiquitin ligase complex that ubiquitinates and degrades NMNAT2.PAM 形成一种非典型的 SCF 泛素连接酶复合物,该复合物使 NMNAT2 泛素化并降解。
J Biol Chem. 2018 Sep 7;293(36):13897-13909. doi: 10.1074/jbc.RA118.002176. Epub 2018 Jul 11.
9
Primary Traumatic Axonopathy in Mice Subjected to Impact Acceleration: A Reappraisal of Pathology and Mechanisms with High-Resolution Anatomical Methods.撞击加速度作用下的小鼠原发性创伤性轴索病:应用高分辨率解剖学方法对病理学和发病机制的再评价。
J Neurosci. 2018 Apr 18;38(16):4031-4047. doi: 10.1523/JNEUROSCI.2343-17.2018. Epub 2018 Mar 22.
10
Incidence and disease burden of chemotherapy-induced peripheral neuropathy in a population-based cohort.基于人群的队列研究中化疗引起的周围神经病变的发生率和疾病负担。
J Neurol Neurosurg Psychiatry. 2018 Jun;89(6):636-641. doi: 10.1136/jnnp-2017-317215. Epub 2018 Feb 8.

轴突变性:机制研究为预防和治疗周围神经病提供了治疗机会。

Axon degeneration: mechanistic insights lead to therapeutic opportunities for the prevention and treatment of peripheral neuropathy.

机构信息

Department of Developmental Biology, Washington University Medical School Saint Louis, Saint Louis, MO, United States.

Needleman Center for Neurometabolism and Axonal Therapeutics, Washington University Medical School Saint Louis, MO, United States.

出版信息

Pain. 2019 May;160 Suppl 1(Suppl 1):S17-S22. doi: 10.1097/j.pain.0000000000001528.

DOI:10.1097/j.pain.0000000000001528
PMID:31008845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6481657/
Abstract

Peripheral neuropathy is the most common neurodegenerative disease affecting hundreds of millions of patients worldwide and is an important cause of chronic pain. Typical peripheral neuropathies are characterized by dysesthesias including numbness, crawling skin, a sensation of "pins and needles," and burning and stabbing pain. In addition, peripheral neuropathy can affect the motor and autonomic systems leading to symptoms such as weakness, constipation, and dysregulation of blood pressure. Peripheral neuropathies can be either hereditary or acquired and are a common consequence of diabetes and treatment with chemotherapy agents. Many neuropathies are due to degeneration of long axons; however, the mechanisms driving axon loss were unknown, and so no therapies are available to preserve vulnerable axons and prevent the development of peripheral neuropathy. With the recent identification of SARM1 as an injury-activated NADase enzyme that triggers axon degeneration, there is now a coherent picture emerging for the mechanism of axonal self-destruction. Here, we will present evidence that inhibiting the SARM1 pathway can prevent the development of peripheral neuropathy, describe the emerging mechanistic understanding of the axon degeneration program, and discuss how these mechanistic insights may be translated to the clinic for the prevention and treatment of peripheral neuropathy and other neurodegenerative disorders.

摘要

周围神经病变是影响全球数亿患者的最常见神经退行性疾病,也是慢性疼痛的重要原因。典型的周围神经病变的特征是感觉异常,包括麻木、爬行感、“刺痛”感以及灼痛和刺痛。此外,周围神经病变还会影响运动和自主神经系统,导致虚弱、便秘和血压失调等症状。周围神经病变可以是遗传性的,也可以是获得性的,是糖尿病和化疗药物治疗的常见后果。许多神经病变是由于长轴突的退化引起的;然而,导致轴突丧失的机制尚不清楚,因此没有可用的疗法来保护易损轴突并预防周围神经病变的发生。随着最近发现 SARM1 作为一种损伤激活的 NAD 酶,触发轴突退化,现在出现了一个连贯的轴突自我破坏的机制图。在这里,我们将提出证据表明,抑制 SARM1 途径可以预防周围神经病变的发生,描述轴突退化程序的新兴机制理解,并讨论这些机制见解如何转化为预防和治疗周围神经病变和其他神经退行性疾病的临床实践。